In its recent third-quarter 2024 earnings report, Novavax highlighted significant advancements in its vaccine portfolio, including the removal of a clinical hold by the U.S. FDA on its ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Novavax's COVID-19 vaccine continues to be its only commercial product and currently has about 2%-3% market share, according ...

Ontada®, a McKesson business and leader in community oncology real-world data, clinical education, and point of care technologies, has announced a strategic collaboration with Datavant, a health data ...

The latest update is out from Novavax ( (NVAX)). Novavax, a leader in vaccine development, announced the FDA’s removal of a clinical hold on their COVID-19-Influenza combination and influenza vaccine ...

With flu season underway and new, developing COVID-19 strains ... There are three types of vaccines available in the United States — Pfizer-BioNTech, Moderna and Novavax. According to the ...

SINGAPORE (Bernama): Singapore’s Health Ministry (MOH) will roll out the ... of severe Covid-19, including seniors and medically vulnerable individuals. "The updated Covid-19 vaccines provide ...

If your side effects are not going away, reach out ... COVID-19. According to the CDC and the National Multiple Sclerosis Society, most people with MS should be fully vaccinated with the COVID-19 ...

Singapore’s Health Ministry will roll out the updated JN1 Pfizer-BioNTech/Comirnaty and JN1 Moderna/Spikevax vaccines from Oct ... at higher risk of severe Covid-19, including seniors and ...

SINGAPORE – Two updated Covid-19 vaccines will be rolled out from ... are comparable with that of previous versions. The roll-out of the vaccines was based on the recommendation of the Expert ...